SLY SYNDROME
Clinical trials for SLY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SLY SYNDROME trials appear
Sign up with your email to follow new studies for SLY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Last-Resort drug access opens for rare sly syndrome patients
Disease control AVAILABLEThis program provides expanded access to Mepsevii for people with MPS VII (Sly Syndrome) who have no other treatment options. It is designed for individual patients on a case-by-case basis. The goal is to offer a potential treatment when no alternatives exist.
Matched conditions: SLY SYNDROME
Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Rare disease study tracks MPS VII over time
Knowledge-focused Recruiting nowThis study monitors up to 50 people with MPS VII (Sly Syndrome) to understand how the disease changes over time. It also checks the long-term safety and effectiveness of the drug vestronidase alfa. Participants may or may not be taking the drug, and the study involves regular che…
Matched conditions: SLY SYNDROME
Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC